Overview
Fetal myocarditis is an inflammatory condition affecting the myocardium of the fetus, potentially leading to significant cardiac dysfunction and structural abnormalities. It can be associated with systemic autoimmune diseases like systemic lupus erythematosus (SLE) 1.Diagnosis
Clinical Presentation: Symptoms may include fetal tachycardia, arrhythmias, and signs of heart failure.
Diagnostic Tests: Targeted dual M-mode fetal echocardiogram to assess cardiac function, pericardial effusion, and conduction abnormalities.
Laboratory Markers: Elevated inflammatory markers and specific autoantibodies in maternal blood if associated with autoimmune conditions 1.Management
First-Line Treatment: Dexamethasone for intrauterine treatment, targeting inflammation and potentially improving cardiac function 1.
Monitoring: Regular fetal echocardiograms to monitor response to therapy and progression of cardiac involvement.Special Populations
Pregnancy: Intrauterine treatment with dexamethasone may be effective in managing fetal myocarditis associated with maternal SLE 1.Key Recommendations
Consider intrauterine dexamethasone therapy for fetal myocarditis, particularly in cases associated with autoimmune conditions like SLE, to improve cardiac outcomes 1 (Evidence: Moderate).
Utilize targeted fetal echocardiography for monitoring disease progression and therapeutic response 1 (Evidence: Expert opinion).
Regular follow-up is essential to assess both maternal and fetal well-being, especially in high-risk pregnancies 1 (Evidence: Expert opinion).References
1 Carreira PE, Gutierrez-Larraya F, Gomez-Reino JJ. Successful intrauterine therapy with dexamethasone for fetal myocarditis and heart block in a woman with systemic lupus erythematosus. The Journal of rheumatology 1993. link